Immunotherapy Company TC BioPharm Partners with Trinity College Dublin to Develop V Delta 1 γδ T Cell-based Cancer Treatments
TC BioPharm (TCB) today announced it is collaborating with Dublin's Trinity College to accelerate in-house production of V delta 1 γδ T cell banks for treatment of solid tumors.